Madisetty Adithya Lakshminarayanasetty

Madisetty Adithya Lakshminarayanasetty

Director Director DIN 07638891
DIN 07638891 First appointment Dec 2016 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 1 historical roles
Total affiliations 1 Since Dec 2016
Shareholding value β€’β€’β€’β€’ Premium profile

About Madisetty Adithya Lakshminarayanasetty

Data last updated:

Madisetty Adithya Lakshminarayanasetty was a Director at Zeke Pharmaceuticals Private Limited (2016–2018). The company operates in Pharma.

DIN 07638891
Primary Designation Director
Industry Pharma
First Appointment 09 Dec 2016

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Zeke Pharmaceuticals Private Limited U24200KA2016PTC098367
Director09 Dec 20162016₹6,381 (FY 2022)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Zeke Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Madisetty Adithya Lakshminarayanasetty

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Madisetty Adithya Lakshminarayanasetty

Madisetty Adithya Lakshminarayanasetty was first appointed on 09 Dec 2016 as Director at Zeke Pharmaceuticals Private Limited.

Madisetty Adithya Lakshminarayanasetty held 1 earlier board appointment: Zeke Pharmaceuticals Private Limited (Director, 09 Dec 2016 to 16 Nov 2018).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available